Mar 3, 2020 | Clinical Outcomes
Presented on November 26, 2018 Authors: Brian S. Metzger, MD, MPH – Austin Infectious Disease Consultants, Austin, TX John S. Adams, MD, FIDSA, FSHEA – Knoxville Infectious Disease Consultants, P.C., Knoxville, TN Jorge R. Bernett, MD – Infectious...Feb 12, 2020 | Clinical Outcomes
Timothy E. Ritter – GI Alliance, Southlake, TX Harry E. Sarles – Digestive Health Associates of Texas, Dallas, TX Samantha A. Mehta – Healix Infusion Therapy, Sugar Land, TX Lucinda J. Van Anglen – Healix Infusion Therapy, Sugar Land, TX View... 
Dec 12, 2019 | Clinical Outcomes
Timothy E. Ritter, MD – GI Alliance, Southlake, TX Chris Fourment, MD – GI Alliance, Southlate, TX Samantha A. Kuten, PharmD – Healix Infusion Therapy, Sugar Land, TX Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Sugar Land, TX View...Oct 25, 2019 | Clinical Outcomes
Chris Fourment – Texas Digestive Disease Consultants, PA, Southlake, TX Timothy E. Ritter – Texas Digestive Disease Consultants, PA, Southlake, TX Samantha A. Kuten – Healix Infusion Therapy, Sugar Land, TX Thomas C. Hardin – Healix Infusion...Oct 25, 2019 | Clinical Outcomes
Timothy E. Ritter – Texas Digestive Disease Consulatants, PA, Southlake, TX Chris Fourment – Texas Digestive Disease Consulatants, PA, Southlake, TX Samantha A. Kuten – Healix Infusion Therapy, Sugar Land, TX Thomas C. Hardin – Healix Infusion...Oct 25, 2019 | Clinical Outcomes, Special Populations
Selected as a Presidential Poster Harry E. Sarles – DHAT Research Institute, Richardson, TX Annette E. Whitney – Digestive Health Associates of Texas, Dallas, TX Samantha A. Kuten – Healix Infusion Therapy, Sugar Land, TX Lucinda J. Van Anglen...
Recent Comments